BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

MYMETICS Corporation 

14, rue de la Colombière

Nyon    1260  Switzerland
Phone: 41-22-363-13-10 Fax: 41-22-363-13-11


SEARCH JOBS


Industry
Biotechnology






 Company News
MYMETICS Corporation Ropes in Dendreon Corporation (DNDN), KPCB Vets as New CEO and Board Members to Restart Vaccine Developer 4/11/2012 7:48:45 AM    More...
MYMETICS Corporation Reclaims Innovative Intra-Nasal Influenza Vaccine 10/4/2011 8:09:23 AM    More...
MYMETICS Corporation Publishes Data From Groundbreaking HIV Vaccine Study 2/15/2011 8:39:40 AM    More...
MYMETICS Corporation HIV Vaccine Shows Strong Preliminary Phase I Data 11/30/2010 9:46:02 AM    More...
MYMETICS Corporation Secures New Patent for Virosome Based Vaccines 11/29/2010 9:44:52 AM    More...
Vivalis Signs New Eb66 Research License With MYMETICS Corporation 9/28/2010 11:11:21 AM    More...
MYMETICS Corporation's Novel HIV Vaccine to Begin New National Institutes of Health (NIH)-Funded Study at University of California, Davis (UCD) 9/13/2010 11:55:13 AM    More...
MYMETICS Corporation' Respiratory Syncytial Virus (RSV) Vaccine Protects From Viral Challenge in Pre-Clinical Study 6/28/2010 10:06:01 AM    More...
MYMETICS Corporation's Phase Ib Malaria Vaccine: Safe, Well Tolerated and Long-Lasting Antibody Response in Children in Tanzania 6/17/2010 9:00:34 AM    More...
MYMETICS Corporation: The First Human Vaccinations of Mymetics' Preventative HIV Vaccine Candidate are Well Tolerated 1/19/2010 8:54:15 AM    More...
1234

//-->